Spyre Therapeutics, Inc 10-Q for FY2023 Q2
Spyre Therapeutics, Inc. (SYRE)
10-Q
2023-08-11
For: 2023-06-30
View Original
Added on
April 10, 2026
About this 10-Q
Spyre Therapeutics, Inc filed this 10-Q on August 11, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $688K
- up 10.1% from $625K a year earlier
- Net loss
- $217.08M
- compared with a net loss of $22.32M a year earlier
- Diluted EPS
- -$2.27
- compared with -$0.27 a year earlier